Search Results - "Vandervorst F"

Interactions Between Direct Oral Anticoagulants and Drugs Involving CYP-Enzymes and P-gp Transporters Detected by a Clinical Decision Support System: A Retrospective Cohort Study.

Authors: Wuyts SCM Bonte S Thielemans N et al.

Source: Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2026 Feb; Vol. 40 (1), pp. 225-239. Date of Electronic Publication: 2025 Apr 08.

Publication Type: Journal Article

Journal Info: Publisher: Kluwer Academic For The International Society For Cardiovascular Pharmacotherapy Country of Publication: United States NLM ID: 8712220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7241 (Electronic) Linking ISSN: 09203206 NLM ISO Abbreviation: Cardiovasc Drugs Ther Subsets: MEDLINE

Cabergoline for migraine prevention (PROTECT): Protocol for a randomized, placebo-controlled, double-blind trial.

Authors: Hjelholt, Astrid Johannesson Laugesen, Kristina Tei, Randi Maria Hanghøj et al.

Source: Cephalalgia Reports. 6/25/2026, Vol. 9, p1-8. 8p.

Quantitative EEG in post-stroke delirium: Spectral and Functional Connectivity Analyses in a Case-Control Study.

Authors: Vandervorst F van Dellen E Gens R et al.

Source: Translational stroke research [Transl Stroke Res] 2026 Apr 28; Vol. 17 (3). Date of Electronic Publication: 2026 Apr 28.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101517297 Publication Model: Electronic Cited Medium: Internet ISSN: 1868-601X (Electronic) Linking ISSN: 18684483 NLM ISO Abbreviation: Transl Stroke Res Subsets: MEDLINE

Achieving International Headache Society-aspired optimal migraine control in fremanezumab-treated patients: A post-hoc analysis of a real-world, prospective study from the GRASP study group.

Authors: Argyriou, Andreas A. Dermitzakis, Emmanouil V. Rikos, Dimitrios et al.

Source: Cephalalgia. Jun2026, Vol. 46 Issue 6, p1-10. 10p.

Placebo or active comparator in chronic migraine trials: Balancing evidence and practicality.

Authors: van Veelen, Nancy Ornello, Raffaele Terwindt, Gisela M. et al.

Source: Cephalalgia. Jun2026, Vol. 46 Issue 6, p1-8. 8p.

Artificial Intelligence Applicability in the Insurance Industry: A Scientometric and Content Analysis Approach.

Authors: Atlasi, Rasha Rezayi, Sorayya Mahdavi, Abdollah et al.

Source: International Journal of Intelligent Systems; 12/28/2025, Vol. 2025, p1-25, 25p

Post-stroke delirium is a predictor of prolonged hospital stay and poor functional outcome at 3 months.

Authors: Boudiba Y Gens R Ourtani A et al.

Source: Frontiers in stroke [Front Stroke] 2026 Jan 15; Vol. 4, pp. 1719748. Date of Electronic Publication: 2026 Jan 15 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Country of Publication: Switzerland NLM ID: 9918540785306676 Publication Model: eCollection Cited Medium: Internet ISSN: 2813-3056 (Electronic) Linking ISSN: 28133056 NLM ISO Abbreviation: Front Stroke Subsets: PubMed not MEDLINE

Comparing the Efficacy and Safety of Anti-CGRP Monoclonal Antibodies Versus Topiramate for Migraine Prophylaxis: Six-Month, Real-World, Intention-to-Treat Retrospective Evidence from the GRASP Study Group.

Authors: Vikelis, Michail Rikos, Dimitrios Argyriou, Andreas A. et al.

Source: Neurology International. Apr2026, Vol. 18 Issue 4, p67. 14p.

Prognostic Value of O -(2-¹⁸F-Fluoroethyl)-l-Tyrosine PET for Patients with Recurrent Glioblastoma.

Authors: Geens, Wietse Buyck, Félix Raes, Laurens et al.

Source: Journal of Nuclear Medicine. Jun2026, Vol. 67 Issue 6, p857-863. 7p.

Two-Year Outcomes and Interictal Burden After Treatment for Medication Overuse Headache.

Authors: Hong, Yooha Kang, Mi-Kyoung Cho, Soo-Jin

Source: Journal of Clinical Medicine. Jun2026, Vol. 15 Issue 12, p4785. 14p.

Cabergoline as a preventive migraine treatment: A randomized clinical pilot trial.

Authors: Hjelholt, Astrid Johannesson Bach, Flemming Winther Kasch, Helge et al.

Source: PLoS ONE. 4/1/2025, Vol. 20 Issue 4, p1-15. 15p.

The clinical outcome of patients starting monoclonal antibodies anti-CGRP with concomitant migraine preventive treatments.

Authors: Fofi, Luisa Altamura, Claudia Marcosano, Marilena et al.

Source: Cephalalgia. Oct2025, Vol. 45 Issue 10, p1-12. 12p.

Redundancy in Growth Factor Receptor Signaling in Adult Astrocytoma Resistance to Small-Molecule Tyrosine Kinase Inhibitors.

Authors: Radu, Roxana Dricu, Anica Tataranu, Ligia Gabriela et al.

Source: International Journal of Molecular Sciences. Feb2026, Vol. 27 Issue 3, p1196. 31p.

Postoperative radiotherapy with concomitant temozolomide plus anlotinib for newly diagnosed glioblastoma: Study protocol for a multicenter, double-blind, randomized phase II trial.

Authors: Chen, Yuanyuan Dong, Baiqiang Liu, Guihong et al.

Source: Glioma (2589-6113). Apr-Jun2022, Vol. 5 Issue 2, p69-76. 8p.

Circulating Neutrophil‐to‐Lymphocyte Ratio Predicts Stroke‐Associated Infection and Poststroke Fatigue Affecting Long‐Term Neurological Outcomes in Stroke Patients.

Authors: Zuo, Lei Geng, Leiyu Cao, Yujia et al.

Source: Mediators of Inflammation. 4/22/2025, Vol. 2025, p1-11. 11p.

Kinase-Targeted Therapies for Glioblastoma.

Authors: Salbini, Maria Formato, Alessia Mongiardi, Maria Patrizia et al.

Source: International Journal of Molecular Sciences. Apr2025, Vol. 26 Issue 8, p3737. 18p.

Development and validation of a nomogram for delirium in the old ischaemic stroke patients.

Authors: Cai, Xiaoyan Yu, Xuefen Qin, Jieying et al.

Source: Psychogeriatrics. Mar2025, Vol. 25 Issue 2, p1-12. 12p.

Treatment Patterns and Healthcare Resource Utilization by Gender and Migraine Frequency in Adult Patients Receiving Galcanezumab Versus Standard of Care Preventive Medications Over 24 months: A United States Retrospective Claims Study.

Authors: Varnado, Oralee J Vu, Michelle Buysman, Erin K et al.

Source: Patient Preference & Adherence. Mar2025, Vol. 18, p543-567. 25p.

One-Year Compliance After Calcitonin Gene-Related Peptide Monoclonal Antibody Therapy for Migraine Patients in a Real-World Setting: A Multicenter Cross-Sectional Study.

Authors: Kang, Mi-kyoung Sohn, Jong-Hee Cha, Myoung-Jin et al.

Source: Journal of Clinical Medicine. Feb2025, Vol. 14 Issue 3, p734. 10p.

Psychopathological variables in chronic migraine patients with different therapeutic approach: psychological profile differences and impact on therapeutic efficacy in real life.

Authors: Migliore, Simone Altamura, Claudia Brunelli, Nicoletta et al.

Source: Neurological Sciences. Dec2024, Vol. 45 Issue 12, p5813-5821. 9p.

Subjects: Botulinum toxin, Botulinum A toxins, Therapeutics, Neurological disorders, Biopsychosocial model